Condition

Myelosuppression clinical trials and research

• 5Clinical trials
• 1Country

Newest Myelosuppression clinical trials

All recruiting trials (5)

• Dynamic risk prediction for severe blood cell suppression in nasopharyngeal cancer

  This study tests a dynamic risk model to see if it can predict grade 3 or higher anemia, low platelets, or low white blood cells during systemic therapy for adults with nasopharyngeal cancer.

  Recruiting Nanfang Hospital, Southern Medical University · Guangzhou, Guangdong · NCT07819656

• Thiopegfilgrastim to prevent bone marrow suppression during chemoradiotherapy for esophageal or lung cancer

  This will try mecapegfilgrastim (a long-acting G-CSF) to prevent low neutrophil counts in adults with esophageal or lung cancer receiving concurrent chemoradiotherapy.

  Recruiting Phase 2 Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07205536

• Trilaciclib given before sacituzumab tirumotecan to protect bone marrow in EGFR-mutated advanced NSCLC

  This trial will test whether giving trilaciclib before sacituzumab tirumotecan helps protect the blood and reduce blood-related side effects in people with advanced EGFR‑mutated non-small cell lung cancer who have stopped responding to EGFR-TKI therapy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06992739

• Trilaciclib plus docetaxel for second-line or later advanced non-small cell lung cancer

  This test gives trilaciclib before docetaxel to see if it protects bone marrow and reduces low blood counts in people with advanced or metastatic non-small cell lung cancer receiving second-line or later chemotherapy.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06929936

• Preventing chemotherapy-related side effects in Ewing's sarcoma patients using Trilaciclib

  This study is testing if adding Trilaciclib to standard chemotherapy can help prevent low blood cell counts in patients with Ewing's sarcoma who haven't had treatment before.

  Recruiting Phase 2 Fudan University · Shanghai, Shanghai Municipality · NCT06699472

Related topics

Quick answers

How many Myelosuppression clinical trials are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →